Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | STS | P08842 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.38 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7302303 | 0.84 | MEN1 (0.43) | MEN1KMT2AALDH1A1SMN1; SMN2GAA | |
| SCHEMBL6268605 | 0.81 | MMP13 (0.59) | GPR119MMP13ADAM17 | |
| SCHEMBL6790862 | 0.81 | ALDH1A1 (0.43) | MEN1KMT2AALDH1A1SMN1; SMN2GAA | |
| SCHEMBL27464048 | 0.79 | MEN1 (0.41) | MEN1KMT2ASMN1; SMN2STSKDM1A | |
| SCHEMBL1003393 | 0.78 | MEN1 (0.51) | MEN1KMT2AALDH1A1SMN1; SMN2STS | |
| SCHEMBL6785770 | 0.78 | POLB (0.38) | ALDH1A1GAALMNAMAPTGPR119 | |
| SCHEMBL2409029 | 0.77 | MMP1 (0.50) | ALDH1A1SMN1; SMN2GAALMNAMMP13 | |
| SCHEMBL27989783 | 0.76 | MEN1 (0.71) | MEN1KMT2AALDH1A1SMN1; SMN2STS | |
| SCHEMBL31117881 | 0.76 | MEN1 (0.53) | MEN1KMT2AALDH1A1SMN1; SMN2STS | |
| SCHEMBL7367231 | 0.75 | MMP13 (0.55) | MEN1KMT2ASTSGPR119MMP13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0780386-B1 | Matrix metalloprotease inhibitors | HOFFMANN LA ROCHE (CH) | 2002-10-02 | — | — | EP | disclosed |
| EP-0780386-A1 | Matrix metalloprotease inhibitors | F. HOFFMANN-LA ROCHE AG (CH) | 1997-06-25 | — | — | EP | disclosed |